Cel
TransQST will develop a Quantitative Systems Toxicology (QST) approach, employing pre-existing data where possible, in order to yield new mechanistic insight into drug-induced toxicity. A central tenet of our programme will be to ensure the human physiological and pharmacological relevance of any test system that has been (or will be) used for generating the input data for modelling. By adopting this approach, we will be able to accurately interpret what happens when test systems are perturbed by drug exposure, and ensure translatability of modelling tools. Mechanistic translational biomarkers are a core aspect of our approach and will be applied in parallel with evidence for understanding how to develop, model and apply such biomarkers in a QST setting. The project is structured in 8 work packages to provide the following outcomes: curate the best available experimental data suitable for modelling adverse drug reactions; provide fit-for-purpose QST models that will address key toxicity measures for liver, kidney, heart and GI-tract; provide quantitative risk assessment for off-target toxicity in man based on in vitro and in vivo models; provide a quantitative mechanistic read-across from species (in vivo and in vitro) currently used for the toxicological evaluation of a new drug; provide definition and applicability of the human physiological relevance of preclinical test systems; provide a battery of translational biomarkers that can be used for quantitative read-across from in vitro systems to man and which relate to intracellular pathways (and systems) relevant to drug toxicity. Led by the University of Liverpool, TransQST brings together 14 partners, characterized by their scientific rigour and proven track record. Collectively they will enable achievement of the goals of the call, thanks to their complementarity, proven ability to work together (and with EFPIA partners), and their understanding of how to ensure the relevance of QST to human biology.
Dziedzina nauki
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicinepharmacology and pharmacydrug safety
- medical and health sciencesclinical medicinecardiologycardiovascular diseasescardiac arrhythmia
- medical and health sciencesbasic medicinepharmacology and pharmacyadverse drug reactions
- medical and health sciencesbasic medicinetoxicology
Słowa kluczowe
Program(-y)
Zaproszenie do składania wniosków
H2020-JTI-IMI2-2015-06-two-stage
Zobacz inne projekty w ramach tego zaproszeniaSystem finansowania
RIA - Research and Innovation actionKoordynator
L69 7ZX Liverpool
Zjednoczone Królestwo
Zobacz na mapie
Uczestnicy (23)
2311 EZ Leiden
Zobacz na mapie
08003 Barcelona
Zobacz na mapie
28006 Madrid
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.
6200 MD Maastricht
Zobacz na mapie
69117 Heidelberg
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
EC2Y 5EB London
Zobacz na mapie
1010 Wien
Zobacz na mapie
Zakończenie uczestnictwa
52074 Aachen
Zobacz na mapie
44139 Dortmund
Zobacz na mapie
3512 KC Utrecht
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
65205 Wiesbaden
Zobacz na mapie
RG21 4FA Basingstoke
Zobacz na mapie
94250 GENTILLY
Zobacz na mapie
151 85 Sodertaelje
Zobacz na mapie
TW89GS Brentford
Zobacz na mapie
92284 Courbevoie
Zobacz na mapie
2340 Beerse
Zobacz na mapie
02200 Espoo
Zobacz na mapie
55218 Ingelheim
Zobacz na mapie
69120 Heidelberg
Zobacz na mapie
W2 6BD London
Zobacz na mapie